Article
Remdesivir is a Delayed Translocation Inhibitor of SARS CoV-2 Replication
2020-12-15
Abstract excerpt
Remdesivir is a nucleoside analog approved by the FDA for treatment of COVID-19. Here, we present a 3.9-Å-resolution cryoEM reconstruction of a remdesivir-stalled RNA-dependent RNA polymerase complex, revealing full incorporation of three copies of remdesivir monophosphate (RMP) and a partially incorporated fourth RMP in the active site. The structure reveals that RMP blocks RNA translocation after incorporatio...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0154a301-3186-5e0b-8f11-73f737980717
- DOI
- 10.2139/ssrn.3749649
